WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Odonate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-12 08:02 am Sale | 2021-03-31 | 13G | Odonate Therapeutics, Inc. ODTC | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | -0 (-100.00%) | Filing |
| 2021-02-04 11:35 am Sale | 2020-12-31 | 13G | Odonate Therapeutics, Inc. ODTC | WELLINGTON MANAGEMENT GROUP LLP | 0 9.790% | -0 (-7.76%) | Filing |
| 2020-09-09 09:10 am Purchase | 2020-08-31 | 13G | Odonate Therapeutics, Inc. ODTC | WELLINGTON MANAGEMENT GROUP LLP | 0 10.830% | 0 (+98.36%) | Filing |